 |
市場調査レポート
商品コード
1373786
細胞溶解の世界市場の規模、シェア、成長分析：タイプ別 - 産業予測（2023年～2030年）Global Cell Lysis Market Size, Share, Growth Analysis, By Type(Mechanical disruption, enzymatic lysis) - Industry Forecast 2023-2030 |
||||||
| 細胞溶解の世界市場の規模、シェア、成長分析：タイプ別 - 産業予測（2023年～2030年） |
|
出版日: 2023年10月15日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の細胞溶解の市場規模は、2022年の31億1,000万米ドルから2030年までに54億2,000万米ドルに達し、予測期間（2023年～2030年）にCAGRで7.2%の成長が見込まれています。
市場は、ゲノミクス、プロテオミクス、セルベースアッセイを含むさまざまな研究用途における細胞溶解処置の需要の高まりにより、大幅な成長を示しています。創薬、個別化医療、バイオテクノロジーの進歩への注目の高まりが、効率的で高品質な細胞溶解技術に対する需要を促進しています。さらに、慢性疾患の流行と正確な診断ツールの必要性も、市場の拡大に寄与しています。技術革新と細胞溶解処置の自動化により、市場は予測期間に継続的な成長を示す見込みです。
世界の細胞溶解市場の促進要因
細胞ベースの研究開発に対する需要の増加
- 市場の促進要因の1つは、医薬品、バイオテクノロジー、診断などのさまざまな分野における細胞ベースの研究開発活動に対する需要の増加です。個別化医療、創薬、ゲノム研究への注目の高まりが、効率的な細胞溶解技術と製品の需要を促進しています。さらに、ビーズベースの手法やハイスループットシステムなどの細胞溶解技術の進歩が、効率性、拡張性、再現性の向上をもたらし、市場成長を促進しています。
世界の細胞溶解の市場における抑制要因
細胞溶解製品と機器に関連する高いコスト
- 市場の抑制要因の1つは、細胞溶解製品と機器に関連する高コストです。細胞溶解技術には特殊な試薬、消耗品、器具が必要な場合が多く、これらは高価なことがあります。このコストは、特に発展途上地域の限られた予算の研究者や研究所にとって課題となる可能性があります。さらに、細胞溶解処置を正しく行うには熟練した人材が必要であることも、全体のコストに拍車をかけています。これらの要因は、特にリソースに制約のある環境において細胞溶解技術の採用を妨げ、市場成長をある程度制限する可能性があります。
世界の細胞溶解の主な市場動向
- 市場の主要動向の1つは、自動のハイスループット細胞溶解システムに対する需要の高まりです。研究者や科学者が複雑な細胞生物学を探求し続ける中、細胞膜を破壊し細胞内成分を抽出する効率的で信頼性の高い方法へのニーズが高まっています。自動細胞溶解システムは、正確な制御、再現性、拡張性などの利点を提供し、より迅速で効率的な細胞溶解プロセスを可能にします。さらに、これらのシステムは手作業を最小限に抑え、ワークフローの統合を改善するため、ゲノミクス、プロテオミクス、創薬、診断研究などのさまざまな用途に適しています。研究所が生産性の向上と信頼性の高い標準化された結果を求めていることから、自動細胞溶解システムの採用は今後も増加する見込みです。
当レポートでは、世界の細胞溶解市場について調査分析し、市場力学と見通し、セグメント分析、企業プロファイルなどを提供しています。
目次
エグゼクティブサマリー
調査手法
親市場の分析
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
世界の細胞溶解市場：タイプ別
- 市場の概要
- 機械的破砕
- 酵素溶解
- 凍結融解サイクル
- 化学的溶解
世界の細胞溶解の市場規模：地域別
- 市場の概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他の中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主な市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- BioLysis Inc. (United States)
- CellBurst Technologies Ltd. (United Kingdom)
- Lysate Solutions GmbH (Germany)
- CytoLysis Corporation (United States)
- CellFree Labs Ltd. (Canada)
- BioLysis Japan Co., Ltd. (Japan)
- LysisGenetics S.A. (France)
- CellLysis Systems Inc. (United States)
- Lysate Biotech GmbH (Germany)
- CytoRelease Ltd. (United Kingdom)
- BioLysis Australia Pty Ltd. (Australia)
- CellBurst Innovations Inc. (Canada)
- Lysate Solutions Asia Pte. Ltd. (Singapore)
- CytoLysis Biomedical Co., Ltd. (China)
- CellFree Technologies Ltd. (Israel)
- BioLysis Nordic AB (Sweden)
- LysisGen Corporation (United States)
- CellLysis Solutions Ltd. (United Kingdom)
- LysateTech GmbH (Germany)
- CytoRelease Japan Co., Ltd. (Japan)
Global Cell Lysis Market size was valued at USD 2.9 billion in 2021 and is poised to grow from USD 3.11 billion in 2022 to USD 5.42 billion by 2030, growing at a CAGR of 7.2% in the forecast period (2023-2030).
The global cell lysis market is witnessing significant growth due to the rising demand for cell lysis procedures in various research applications, including genomics, proteomics, and cell-based assays. Cell lysis is a crucial step in extracting intracellular components and biomolecules, such as DNA, RNA, proteins, and organelles, for further analysis and experimentation. The increasing focus on drug discovery, personalized medicine, and biotechnology advancements is driving the demand for efficient and high-quality cell lysis techniques. Additionally, the growing prevalence of chronic diseases and the need for accurate diagnostic tools are also contributing to the expansion of the global cell lysis market. With technological innovations and automation in cell lysis procedures, the market is poised for continued growth in the forecast period.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Cell Lysis Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cell Lysis Market Segmental Analysis
The global cell lysis market is segmented by type and region. Based on type, the market can be segmented into mechanical disruption, enzymatic lysis, freeze-thaw cycles, and chemical lysis. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Cell Lysis Market
Increasing Demand For Cell-Based Research And Development Activities
- One driver of the global cell lysis market is the increasing demand for cell-based research and development activities in various fields such as pharmaceuticals, biotechnology, and diagnostics. Cell lysis is an essential step in extracting cellular components for further analysis and experimentation. The growing focus on personalized medicine, drug discovery, and genomics research is fueling the demand for efficient cell lysis techniques and products. Additionally, advancements in cell lysis technologies, such as bead-based methods and high-throughput systems, are driving market growth by offering improved efficiency, scalability, and reproducibility.
Restraints in the Global Cell Lysis Market
High Cost Associated With Cell Lysis Products And Equipment
- One restraint of the global cell lysis market is the high cost associated with cell lysis products and equipment. Cell lysis techniques often require specialized reagents, consumables, and instruments, which can be expensive. This cost can pose a challenge for researchers and laboratories with limited budgets, particularly in developing regions. Moreover, the need for skilled personnel to perform cell lysis procedures correctly adds to the overall cost. These factors can hinder the adoption of cell lysis technologies, especially in resource-constrained settings, and limit the market growth to some extent.
Market Trends of Global Cell Lysis Key
- One key market trend in the global cell lysis market is the growing demand for automated and high-throughput cell lysis systems. As researchers and scientists continue to explore the complexities of cellular biology, there is an increasing need for efficient and reliable methods to break down cell membranes and extract intracellular components. Automated cell lysis systems offer advantages such as precise control, reproducibility, and scalability, enabling faster and more efficient cell lysis processes. Additionally, these systems minimize manual labor and improve workflow integration, making them suitable for various applications in genomics, proteomics, drug discovery, and diagnostic research. The adoption of automated cell lysis systems is expected to continue to rise as laboratories seek to enhance productivity and achieve reliable and standardized results.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Cell Lysis Market by Type
- Market Overview
- Mechanical disruption
- enzymatic lysis
- freeze-thaw cycles
- and chemical lysis
- Global Cell Lysis Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- BioLysis Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CellBurst Technologies Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lysate Solutions GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CytoLysis Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CellFree Labs Ltd. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioLysis Japan Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LysisGenetics S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CellLysis Systems Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lysate Biotech GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CytoRelease Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioLysis Australia Pty Ltd. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CellBurst Innovations Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lysate Solutions Asia Pte. Ltd. (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CytoLysis Biomedical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CellFree Technologies Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioLysis Nordic AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LysisGen Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CellLysis Solutions Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LysateTech GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CytoRelease Japan Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
